Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 9
2004 6
2005 5
2006 9
2007 5
2008 5
2009 6
2010 5
2011 9
2012 6
2013 13
2014 7
2015 7
2016 9
2017 2
2018 2
2019 2
2020 3
2021 3
2022 17
2023 10
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
[Antipsychotics].
Yamada H, Hashimoto R. Yamada H, et al. Brain Nerve. 2023 May;75(5):579-584. doi: 10.11477/mf.1416202382. Brain Nerve. 2023. PMID: 37194535 Japanese.
Antidepressants for social anxiety disorder: A systematic review and meta-analysis.
Mitsui N, Fujii Y, Asakura S, Imai H, Yamada H, Yoshinaga N, Kanai Y, Inoue T, Shimizu E. Mitsui N, et al. Among authors: yamada h. Neuropsychopharmacol Rep. 2022 Dec;42(4):398-409. doi: 10.1002/npr2.12275. Epub 2022 Jul 18. Neuropsychopharmacol Rep. 2022. PMID: 35848723 Free PMC article. Review.
Assessment and Treatment of Eating Disorders.
Yoshiuchi K, Yamada H, Takakura S, Isobe M, Maruyama K, Nagata T. Yoshiuchi K, et al. Among authors: yamada h. J Nutr Sci Vitaminol (Tokyo). 2022;68(Supplement):S46-S48. doi: 10.3177/jnsv.68.S46. J Nutr Sci Vitaminol (Tokyo). 2022. PMID: 36437014 Free article.
Management of unspecified anxiety disorder: Expert consensus.
Sakurai H, Inada K, Aoki Y, Takeshima M, Ie K, Kise M, Yoshida E, Tsuboi T, Yamada H, Hori H, Inada Y, Shimizu E, Mishima K, Watanabe K, Takaesu Y. Sakurai H, et al. Among authors: yamada h. Neuropsychopharmacol Rep. 2023 Jun;43(2):188-194. doi: 10.1002/npr2.12323. Epub 2023 Feb 21. Neuropsychopharmacol Rep. 2023. PMID: 36811273 Free PMC article.
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.
Hasegawa N, Yasuda Y, Yasui-Furukori N, Yamada H, Hori H, Ichihashi K, Takaesu Y, Iida H, Muraoka H, Kodaka F, Iga JI, Hashimoto N, Ogasawara K, Ohi K, Fukumoto K, Numata S, Tsuboi T, Usami M, Hishimoto A, Furihata R, Kishimoto T, Nakamura T, Katsumoto E, Ochi S, Nagasawa T, Atake K, Kubota C, Komatsu H, Yamagata H, Ide K, Takeshima M, Kido M, Kikuchi S, Okada T, Matsumoto J, Miura K, Shimazu T, Inada K, Watanabe K, Hashimoto R. Hasegawa N, et al. Among authors: yamada h. Psychiatry Clin Neurosci. 2023 Oct;77(10):559-568. doi: 10.1111/pcn.13578. Epub 2023 Sep 8. Psychiatry Clin Neurosci. 2023. PMID: 37684711
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project.
Hashimoto N, Yasui-Furukori N, Hasegawa N, Ishikawa S, Hori H, Iida H, Ichihashi K, Miura K, Matsumoto J, Numata S, Kodaka F, Furihata R, Ohi K, Ogasawara K, Iga JI, Muraoka H, Komatsu H, Takeshima M, Atake K, Kido M, Nakamura T, Kishimoto T, Hishimoto A, Onitsuka T, Okada T, Ochi S, Nagasawa T, Makinodan M, Yamada H, Tsuboi T, Yamada H, Inada K, Watanabe K, Hashimoto R. Hashimoto N, et al. Among authors: yamada h. BMC Psychiatry. 2023 Jun 28;23(1):473. doi: 10.1186/s12888-023-04908-4. BMC Psychiatry. 2023. PMID: 37380997 Free PMC article.
Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics: A Nationwide Real-World Study in Japan.
Onitsuka T, Okada T, Hasegawa N, Tsuboi T, Iga JI, Yasui-Furukori N, Yamada N, Hori H, Muraoka H, Ohi K, Ogasawara K, Ochi S, Takeshima M, Ichihashi K, Fukumoto K, Iida H, Yamada H, Furihata R, Makinodan M, Takaesu Y, Numata S, Komatsu H, Hishimoto A, Kido M, Atake K, Yamagata H, Kikuchi S, Hashimoto N, Usami M, Katsumoto E, Asami T, Kubota C, Matsumoto J, Miura K, Hirano Y, Watanabe K, Inada K, Hashimoto R. Onitsuka T, et al. Among authors: yamada h. J Clin Psychopharmacol. 2023 Jul-Aug 01;43(4):365-368. doi: 10.1097/JCP.0000000000001704. Epub 2023 May 23. J Clin Psychopharmacol. 2023. PMID: 37216369
A prospective investigation of impacts of comorbid attention deficit hyperactivity disorder (ADHD) on clinical features and long-term treatment response in adult patients with obsessive-compulsive disorder (OCD).
Miyauchi M, Matsuura N, Mukai K, Hashimoto T, Ogino S, Yamanishi K, Yamada H, Hayashida K, Matsunaga H. Miyauchi M, et al. Among authors: yamada h. Compr Psychiatry. 2023 Aug;125:152401. doi: 10.1016/j.comppsych.2023.152401. Epub 2023 Jul 13. Compr Psychiatry. 2023. PMID: 37454485 Free article.
Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia.
Okada T, Hori H, Hasegawa N, Murata A, Kyou Y, Kodaka F, Iida H, Ochi S, Takaesu Y, Tsuboi T, Iga JI, Ichihashi K, Muraoka H, Furihata R, Yasui-Furukori N, Usami M, Onitsuka T, Ogasawara K, Tagata H, Takeshima M, Ohi K, Numata S, Hashimoto N, Yamada H, Makinodan M, Komatsu H, Hishimoto A, Yamagata H, Kido M, Kubota C, Atake K, Yamada H, Nagasawa T, Matsumoto J, Miura K, Inada K, Watanabe K, Suda S, Hashimoto R. Okada T, et al. Among authors: yamada h. J Clin Psychopharmacol. 2022 Nov-Dec 01;42(6):591-593. doi: 10.1097/JCP.0000000000001604. Epub 2022 Oct 3. J Clin Psychopharmacol. 2022. PMID: 36193896 No abstract available.
130 results